- Home
- CRWS vs BCAB Comparison
CRWS vs BCAB Comparison
Compare CRWS & BCAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRWS
- BCAB
- Stock Information
- Founded
- CRWS 1957
- BCAB 2007
- Country
- CRWS United States
- BCAB United States
- Employees
- CRWS N/A
- BCAB N/A
- Industry
- CRWS Textiles
- BCAB Medicinal Chemicals and Botanical Products
- Sector
- CRWS Consumer Discretionary
- BCAB Health Care
- Exchange
- CRWS Nasdaq
- BCAB Nasdaq
- Market Cap
- CRWS 30.5M
- BCAB 31.5M
- IPO Year
- CRWS N/A
- BCAB 2020
- Fundamental
- Price
- CRWS $2.98
- BCAB $0.77
- Analyst Decision
- CRWS
- BCAB Hold
- Analyst Count
- CRWS 0
- BCAB 3
- Target Price
- CRWS N/A
- BCAB $1.00
- AVG Volume (30 Days)
- CRWS 41.3K
- BCAB 1.0M
- Earning Date
- CRWS 11-11-2025
- BCAB 11-06-2025
- Dividend Yield
- CRWS 10.74%
- BCAB N/A
- EPS Growth
- CRWS N/A
- BCAB N/A
- EPS
- CRWS N/A
- BCAB N/A
- Revenue
- CRWS $86,516,000.00
- BCAB $11,000,000.00
- Revenue This Year
- CRWS N/A
- BCAB N/A
- Revenue Next Year
- CRWS N/A
- BCAB N/A
- P/E Ratio
- CRWS N/A
- BCAB N/A
- Revenue Growth
- CRWS N/A
- BCAB N/A
- 52 Week Low
- CRWS $2.76
- BCAB $0.24
- 52 Week High
- CRWS $4.96
- BCAB $2.53
- Technical
- Relative Strength Index (RSI)
- CRWS 49.50
- BCAB 80.31
- Support Level
- CRWS $2.96
- BCAB $0.44
- Resistance Level
- CRWS $3.07
- BCAB $0.46
- Average True Range (ATR)
- CRWS 0.08
- BCAB 0.07
- MACD
- CRWS -0.01
- BCAB 0.04
- Stochastic Oscillator
- CRWS 13.64
- BCAB 86.77
About CRWS Crown Crafts Inc
Crown Crafts Inc operates in the infant and toddler products segment of the consumer products industry through its wholly-owned subsidiaries. The infant and toddler products segment consists of infant and toddler bedding, bibs, soft bath products, disposable products, and accessories. The company serves a diverse range of customers including mass merchants, mid-tier retailers, juvenile specialty stores, value channel stores, grocery and drug stores, restaurants, internet accounts, wholesale clubs, and internet-based retailers. The company's brands include NoJo, Neat Solutions, Sassy, and Carousel. Its products are marketed under a variety of company-owned trademarks, under trademarks licensed from others, and as private-label goods.
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.